Rollover Study of VX-770 in Cystic Fibrosis Subjects

NCT01117012 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

192

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Ivacaftor

Sponsor

Vertex Pharmaceuticals Incorporated

Collaborators

[object Object]